Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
At close: Sep 4, 2026 · 4:00 PM EDT

Compugen (CGEN) Other Non-Current Assets (2009 - 2026)

Compugen (CGEN) posted quarterly Other Non-Current Assets of $1.3 million for Q1 2026, down 20.84% year-over-year from $1.6 million in Q1 2025, and little changed on a QoQ basis from $1.3 million in Q4 2025.

Analysis

Compugen (CGEN) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Compugen has reported Other Non-Current Assets for 18 years, with the latest figure at $1.3 million in Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $1.3 million, down 20.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 20.84% YoY), and the FY2025 annual result was $1.3 million, down 31.51% from the prior year.
  • Other Non-Current Assets held at $1.3 million in Q1 2026, from $1.3 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $1.9 million in Q1 2022 and troughed at $922000.0 in Q2 2024.
  • A 5-year average of $1.6 million and a median of $1.7 million in 2025 frame the typical range for Other Non-Current Assets.
  • The widest annual swing landed in 2024, when Other Non-Current Assets tumbled 51.78%; it then surged 88.5% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $1.9 million in 2022, then plunged by 35.07% to $1.2 million in 2023, then jumped by 53.12% to $1.9 million in 2024, then plunged by 31.51% to $1.3 million in 2025, then advanced by 0.15% to $1.3 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Compugen 242.44 Mn 156.82 Mn -92,000.00 1.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.31 Mn
Mar 31, 2026 1.30 Mn
Dec 31, 2025 1.29 Mn
Sep 30, 2025 1.73 Mn
Jun 30, 2025 1.74 Mn
Mar 31, 2025 1.64 Mn
Dec 31, 2024 1.89 Mn
Sep 30, 2024 1.10 Mn
Mar 31, 2024 934,000.00
Dec 31, 2023 365,000.00
Sep 30, 2023 1.91 Mn
Jun 30, 2023 615,000.00
Mar 31, 2023 1.91 Mn
Dec 31, 2022 362,000.00
Sep 30, 2022 1.91 Mn
Jun 30, 2022 363,000.00
Mar 31, 2022 1.92 Mn
Dec 31, 2021 3.13 Mn
Sep 30, 2021 1.91 Mn
Jun 30, 2021 681,000.00